Top Clicks This Month

4-(5-Methyl-1,3,4-oxadiazol-2-yl)benzylamine - CAS 946409-19-4

Quick Inquiry

Name:
* Email:
* Service & Products of Interest:
* Quantity:
* Verification code:
Please input "bocsci" as verification code.
Category
Main Product
Product Name
4-(5-Methyl-1,3,4-oxadiazol-2-yl)benzylamine
Catalog Number
946409-19-4
Synonyms
4-(5-METHYL-1,3,4-OXADIAZOL-2-YL)BENZYLAMINE;4-(5-methyl-1,3,4- oxadiazol -2-yl)-benzenemethanamine
CAS Number
946409-19-4
Molecular Weight
189.21
Molecular Formula
C10H11N3O
COA
Inquire
MSDS
Inquire
Structure
CAS 946409-19-4 4-(5-Methyl-1,3,4-oxadiazol-2-yl)benzylamine
Specification
Purity
95%
Boiling Point
349.1ºC at 760 mmHg
Density
1.18 g/cm3
Reference Reading
1.Utility of small-animal positron emission tomographic imaging of rats for preclinical development of drugs acting on the serotonin transporter.
Saijo T1, Maeda J, Okauchi T, Maeda J, Morio Y, Kuwahara Y, Suzuki M, Goto N, Suzuki K, Higuchi M, Suhara T. Int J Neuropsychopharmacol. 2009 Sep;12(8):1021-32. doi: 10.1017/S1461145709000042. Epub 2009 Feb 23.
Visualization of neurotransmission components in living small animals using positron emission tomography (PET) has the potential of contributing to the preclinical development of neuroactive drugs, although it is yet to be examined whether quantitative animal PET data on candidate compounds can be extrapolated to humans. Here, we investigated the comparability of the occupancies of serotonin transporter (5-HTT) by therapeutic agents in rat PET studies with our predetermined data from ex- vivo animal experiments and clinical PET scans. Rats were treated with varying doses of fluvoxamine and a newly developed compound, (2S)-1-[4-(3,4-dichlorophenyl) piperidin-1-yl]-3-[2-(5-methyl-1,3,4-oxadiazol-2-yl)benzo[b]furan-4-yloxy]propan-2-ol monohydrochloride (Wf-516), and underwent PET scans with [11C]3-amino-4-(2-dimethylaminomethyl-phenylsulfanyl)-benzonitrile ([11C]DASB), a selective radioligand for in-vivo quantification of 5-HTT. PET images indicated a reduction of [11C]DASB binding to 5-HTT as a function of the doses and/or plasma concentrations of fluvoxamine and Wf-516.
2005 - BOC Sciences | All rights reserved
BOCSciences
X CLOSE
BOCSciences
X CLOSE
BOCSciences
X CLOSE
BOCSciences
X CLOSE
BOCSciences
X CLOSE
BOCSciences
X CLOSE
BOCSciences
X CLOSE
BOCSciences
X CLOSE
BOCSciences
X CLOSE
BOCSciences
X CLOSE